Generic Drug and API Manufacturers recognize that by going paperless they will need to be 21 CFR Part 11 and Annex 11 compliant in all areas: IT infrastructure, SOPs, software product features and so on. The benefits of an electronic system are an immediate improvement in productivity and a significantly lower risk of 483 Warning Letters or non-conformances.
In using the QUMAS Compliance Platform, Organizations can be confident that they are complying with CFR Part 11 as well as Annex 11 in completing Electronic Signatures and utilizing a fully compliant electronic audit trail that supports point in time reporting.
If your organization is aiming to go paperless, download this informative webinar The Sounds of Compliance - Shredding Master Documents by Dr. Joerg Stueben, Business Project Manager IDEA for Controlled Documents, Boehringer Ingelheim.
If you are interested in SharePoint and 21 CFR Part 11, download this webinar on Qualifying SharePoint 2010 and Delivering a 21 CFR Part 11-Compliant Quality Management Solution
Watch these webinars to learn more about the changes in the regulation of the Generics Industry, and how to address them: